Meet Our Team

Our Founders

Michael Tsipursky, MD, MS

CEO, Co-Founder

LinkedIn

Vitreoretinal specialist, former Department Chair and Assistant Medical Director at Carle Health. Bringing 15 years of clinical experience with multiple book chapters and publications on various retinal pathology and surgery. Experience in multiple clinical trials as a primary investigator. Long track record of translational research experience.

Professor Joseph Irudayaraj, Ph.D

CSO, Co-Founder

LinkedIn

Professor Joseph Irudayaraj has a doctorate in biological engineering, and a dual masters in bioengineering and computer sciences. As one of the leaders in the application of nanotechnology in biomedicine, his group has developed biosensors, drug delivery approaches, and single molecule tools for quantifying mRNA targets and protein interactions for a range of biomedical applications. His team has published over 350 refereed journal articles, supervised over 40 graduate students and 25 postdoctoral scholars. He has taught at Utah State University, Pennsylvania State University, and Purdue University. At present he is the Founder Professor of Bioengineering at the University of Illinois at Urbana-Champaign.

Our Team

Mathew Cherian, Ph.D

Vice President of Operations and Development

LinkedIn

Dr. Mathew Cherian is a pharmaceutical industry veteran with 30+ years of experience. He held key roles in drug development for major companies like Pharmacia and Pfizer in the US and Italy. His expertise includes sterile dosage forms like liposomes, lipid nanoparticles, and emulsions. Mathew serves on the International Pharmaceutical Society’s Executive Committee and holds a PhD in chemical engineering from the University of Rhode Island.

Wen Ren, Ph.D

Research Scientist (Sub-Award)

LinkedIn

Dr. Wen Ren has his B.S. in Chemistry and a Ph.D. in Analytical Chemistry. His expertise is in nanoparticle technology and nanochemistry. He has over 10 years of experience in developing and utilizing nanostructures and functionalization strategies for enhanced detection of disease biomarkers. He has developed surface-enhanced Raman spectroscopy probes, highly sensitive lateral flow assays, and fabrication and characterization of nanodelivery systems.

Le choix d’une plateforme de jeu est crucial, et https://fatboss.net/ répond à de nombreux critères essentiels pour les joueurs. Les jeux à mise variable permettent de passer d’une mise prudente à une mise audacieuse en un seul clic. L’absence de frais cachés sur les dépôts renforce la transparence financière de la plateforme. La plateforme propose des défis hebdomadaires avec des classements et des récompenses pour les meilleurs joueurs. On ne peut que saluer l’effort continu de cette plateforme pour rester au sommet de son art.